Biliary tract FDG uptake secondary to stent placement

被引：7

作者：

Lin, EC ^{[1
]}

Studley, M ^{[1
]}

机构：

[1] Virginia Mason Med Ctr, Dept Radiol, Seattle, WA 98111 USA

来源：

CLINICAL NUCLEAR MEDICINE | 2003年 / 28卷 / 04期

关键词：

biliary tract; F-18; fluorodeoxyglucose; positron emission tomography;

D O I：

10.1097/01.RLU.0000057561.68938.8B

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：318 / 319

页数：2

共 6 条

[1]

Delbeke D, 1999, J NUCL MED, V40, P1784

[2] FDG PET in the diagnosis of hilar cholangiocarcinoma [J].

Fritscher-Ravens, A ;

Bohuslavizki, KH ;

Broering, DC ;

Jenicke, L ;

Schäfer, H ;

Buchert, R ;

Rogiers, X ;

Clausen, M .

NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (12) :1277-1285

[3]

KEIDING S, 1998, HEPATOLOGY, V28, P611

[4] Positron emission tomography with [18F]fluoro-2-deoxy-d-glucose for diagnosis and staging of bile duct cancer [J].

Kluge, R ;

Schmidt, F ;

Caca, K ;

Barthel, H ;

Hesse, S ;

Georgi, P ;

Seese, A ;

Huster, D ;

Berr, F .

HEPATOLOGY, 2001, 33 (05) :1029-1035

[5] Radionuclide imaging of hepatic and biliary disease [J].

Lin, EC ;

Kuni, CC .

SEMINARS IN LIVER DISEASE, 2001, 21 (02) :179-194

[6] Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants [J].

Shreve, PD ;

Anzai, Y ;

Wahl, RL .

RADIOGRAPHICS, 1999, 19 (01) :61-77

← 1 →